APA (7th ed.) Citation

Darwish, I. A., Alzoman, N. Z., Khalil, N. N., & Darwish, H. W. (2023). Development of a highly sensitive chemiluminescence immunoassay using a novel signal-enhanced detection system for quantitation of durvalumab, an immune-checkpoint inhibitor monoclonal antibody used for immunotherapy of lung cancer. Elsevier.

Chicago Style (17th ed.) Citation

Darwish, Ibrahim A., Nourah Z. Alzoman, Nehal N.Y Khalil, and Hany W. Darwish. Development of a Highly Sensitive Chemiluminescence Immunoassay Using a Novel Signal-enhanced Detection System for Quantitation of Durvalumab, an Immune-checkpoint Inhibitor Monoclonal Antibody Used for Immunotherapy of Lung Cancer. Elsevier, 2023.

MLA (9th ed.) Citation

Darwish, Ibrahim A., et al. Development of a Highly Sensitive Chemiluminescence Immunoassay Using a Novel Signal-enhanced Detection System for Quantitation of Durvalumab, an Immune-checkpoint Inhibitor Monoclonal Antibody Used for Immunotherapy of Lung Cancer. Elsevier, 2023.